The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria
Open accessAbstract
Background and Aims: Fatal outcome of opioid overdose, once detected, is preventable through timely administration of the antidote naloxone. Take‐home naloxone provision directly to opioid users for emergency use has been implemented recently in more than 15 countries worldwide, albeit mainly as pilot schemes and without formal evaluation. This systematic review assesses the effectiveness of take‐home naloxone, with two specific aims: (1) to study the impact of take‐home naloxone distribution on overdose‐related mortality; and (2) to assess the safety of take‐home naloxone in terms of adverse events. Methods: PubMed, MEDLINE and PsychINFO were searched for English‐language peer‐reviewed publications (randomized or observational trials) using the Boolean search query: (opioid OR opiate) AND overdose AND prevention. Evidence was evaluated using the nine Bradford Hill criteria for causation, devised to assess a potential causal relationship between public health interventions and clinical outcomes when only observational data are available. Results: A total of 1397 records (1164 after removal of duplicates) were retrieved, with 22 observational studies meeting eligibility criteria. Due to variability in size and quality of the included studies, meta‐analysis was dismissed in favour of narrative synthesis. From eligible studies, we found take‐home naloxone met all nine Bradford Hill criteria. The additional five World Health Organization criteria were all either met partially (two) or fully (three). Even with take‐home naloxone administration, fatal outcome was reported in one in 123 overdose cases (0.8%; 95% confidence interval = 0.4, 1.2). Conclusions: Take‐home naloxone programmes are found to reduce overdose mortality among programme participants and in the community and have a low rate of adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.08.012 · Cited by 2,698
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Penfold, R. B., & Zhang, F. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.08.002 · Cited by 1,150
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856
A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000034 · Cited by 488
Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal
Coffin, P. O., & Sullivan, S. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00003 · Cited by 343
Wodak, A., & Cooney, A. (2006) · Substance Use & Misuse · doi:10.1080/10826080600669579 · Cited by 311
Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose
Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.146647 · Cited by 250
Seal, K. H. (2005) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jti053 · Cited by 244
Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths
Maxwell, S., Bigg, D., Stanczykiewicz, K., & Carlberg-Racich, S. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_11 · Cited by 242
Strang, J., Manning, V., Mayet, S., Best, D., Titherington, E., Santana, L., Offor, E., & Semmler, C. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02314.x · Cited by 198
Self-citationMueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1010032 · Cited by 194
Wagner, K. D., Valente, T. W., Casanova, M., Partovi, S. M., Mendenhall, B. M., Hundley, J. H., Gonzalez, M., & Unger, J. B. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.01.003 · Cited by 193
Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
Enteen, L., Bauer, J., McLean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9495-8 · Cited by 187
Doe-Simkins, M., Quinn, E., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-297 · Cited by 175
Heroin overdose: the case for take-home naloxone
Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996) · BMJ · doi:10.1136/bmj.312.7044.1435 · Cited by 172
Self-citationBennett, A. S., Bell, A., Tomedi, L., Hulsey, E. G., & Kral, A. H. (2011) · Journal of Urban Health · doi:10.1007/s11524-011-9600-7 · Cited by 160
Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes
Dettmer, K., Saunders, B., & Strang, J. (2001) · BMJ · doi:10.1136/bmj.322.7291.895 · Cited by 158
Self-citationOpioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
Dwyer, K. H., Walley, A. Y., Langlois, B. K., Mitchell, P. M., Nelson, K. P., Cromwell, J. W., & Bernstein, E. (2015) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2015.2.24909 · Cited by 148
Galea, S., Worthington, N., Piper, T. M., Nandi, V., Curtis, M., & ROSENTHAL, D. M. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.07.020 · Cited by 131
Evaluation of a Naloxone Distribution and Administration Program in New York City
Piper, T. M., Stancliff, S., Rudenstine, S., Sherman, S. G., Nandi, V., Clear, A., & Galea, S. (2008) · Substance Use & Misuse · doi:10.1080/10826080701801261 · Cited by 130
Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses
Lankenau, S. E., Wagner, K. D., Silva, K., Kecojević, A., Iverson, E., McNeely, M., & Kral, A. H. (2012) · Journal of Community Health · doi:10.1007/s10900-012-9591-7 · Cited by 123
The ratio of non‐fatal to fatal heroin overdose
Darke, S. G., Mattick, R. P., & Degenhardt, L. J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00474.x · Cited by 120
Wagner, K. D., Davidson, P. J., Iverson, E., Washburn, R., Burke, E., Kral, A. H., McNeeley, M., Bloom, J. J., & Lankenau, S. E. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.07.003 · Cited by 116
Williams, A., Marsden, J., & Strang, J. (2013) · Addiction · doi:10.1111/add.12360 · Cited by 114
Self-citationOpioid overdose prevention with intranasal naloxone among people who take methadone
Walley, A. Y., Doe-Simkins, M., Quinn, E., Pierce, C., Xuan, Z., & Ozonoff, A. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.07.004 · Cited by 107 · cited 5×
“Even when methadone patients were recruited specifically into a THN programme [33], more than 90% of witnessed (and reversed) overdoses were heroin-induced.”
BackgroundInfluentialA quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program
Banjo, O., Tzemis, D., Al-Qutub, D., Amlani, A., Kesselring, S., & Buxton, J. A. (2014) · CMAJ Open · doi:10.9778/cmajo.20140008 · Cited by 105
Bennett, T. H., & Holloway, K. R. (2012) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2012.658104 · Cited by 93
Rowe, C. L., Santos, G., Vittinghoff, E., Wheeler, E., Davidson, P. J., & Coffin, P. O. (2015) · Addiction · doi:10.1111/add.12961 · Cited by 84
Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2010.0935 · Cited by 74
Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?
Gaston, R. L., Best, D. W., Manning, V., & Day, E. (2009) · Harm Reduction Journal · doi:10.1186/1477-7517-6-26 · Cited by 69
Obesity interventions for people with a learning disability: an integrative literature review
Jinks, A., Cotton, A., & Rylance, R. T. (2010) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05508.x · Cited by 64
The "lessons" of the Australian "heroin shortage"
Degenhardt, L. J., Day, C., Gilmour, S., & Hall, W. (2006) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-1-11 · Cited by 61
Coffin, P. O., & Sullivan, S. D. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.811080 · Cited by 50
Responsible management and use of a personal take-home naloxone supply: A pilot project
McAuley, A., Lindsay, G., Woods, M., & Louttit, D. (2010) · Drugs Education Prevention and Policy · doi:10.3109/09687630802530712 · Cited by 47
Opioid overdose prevention and naloxone distribution in Rhode Island.
Yokell, M. A., Green, T. C., Bowman, S., McKenzie, M., & Rich, J. D. (2011) · PubMed · Cited by 35
Kan, M., Gall, J. A., Latypov, A. B., Gray, R., Bakpayev, M., Alisheva, D., Rakhmatova, K., & Sadieva, A. S. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.01.005 · Cited by 15
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Self-citationSoar, J., Berg, K. M., Andersen, L. W., Böttiger, B. W., Cacciola, S., Callaway, C. W., Couper, K., Cronberg, T., D’Arrigo, S., Deakin, C. D., et al. (2020) · Resuscitation · doi:10.1016/j.resuscitation.2020.09.012 · Cited by 616
Naloxone dosage for opioid reversal: current evidence and clinical implications
Rzasa Lynn, R., & Galinkin, J. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617744161 · Cited by 346
Medication Treatment of Opioid Use Disorder
Bell, J., & Strang, J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.06.020 · Cited by 328
Self-citationOlasveengen, T. M., Mancini, M. E., Perkins, G. D., Avis, S., Brooks, S., Castrén, M., Chung, S. P., Considine, J., Couper, K., Escalante, R., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000892 · Cited by 257
Metadata
- Authors
- McDonald, R., & Strang, J.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2016-03-30
- Volume
- 111
- Issue
- 7
- Pages
- 1177-1187
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2331803526
- Cited by
- 471
- References
- 40
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.